(Q53988244)
Statements
Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study. (English)
1 reference
Reinhart K
1 reference
Wiegand-Löhnert C
1 reference
Kaul M
1 reference
Withington S
1 reference
Treacher D
1 reference
Eckart J
1 reference
Willatts S
1 reference
Bouza C
1 reference
Krausch D
1 reference
Stockenhuber F
1 reference
Eiselstein J
1 reference
Daum L
1 reference
Kempeni J
1 reference
1 May 1996
1 reference
24
1 reference
733-742
1 reference
5
1 reference
Identifiers
1 reference